Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04921982

Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD

The Efficacy of Traumatic Memory Modification Using a Memory Reconsolidation Procedure Under Propranolol Among Adolescents With Post-traumatic Stress Disorder

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to demonstrate the effectiveness of propranolol in blocking reconsolidation by reducing PTSD symptoms in the short and long term in adolescents with PTSD for more than 3 months.

Conditions

Interventions

TypeNameDescription
DRUGPropranololOral administration of Propranolol, 90 minutes prior to a brief memory reactivation session, performed by a trained nurse once a week for six consecutive weeks.
DRUGPlaceboOral administration of Placebo, 90 minutes prior to a brief memory reactivation session, performed by a trained nurse, once a week for six consecutive weeks.

Timeline

Start date
2024-10-01
Primary completion
2025-03-01
Completion
2026-06-01
First posted
2021-06-10
Last updated
2025-09-08

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04921982. Inclusion in this directory is not an endorsement.